2024

Phoenix-Micron Enhances OCT Imaging with AI-powered OCT Segmentation

Phoenix-Micron, Inc. and ArtiKode Intelligence Collaborate to Bring Automated, AI-Powered OCT Segmentation to MICRON Software Suite Bend, OR, USA – April 23, 2024 – Phoenix-Micron, Inc. (“Phoenix”), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, today announced a collaboration with ArtiKode Intelligence (“ArtiKode”), a Valencia, Spain-based innovator in artificial intelligence (AI)

2024

MICRON Imaging Systems: Powering 900 Scientific Publications

The ability to see the world around us is a gift that’s easy to take for granted, until it’s threatened by the onset of a devastating eye disease. For those facing the reality of vision loss, ophthalmic research represents a beacon of hope, offering the promise of new treatments and therapies to preserve or restore

2023

Small zebrafish are impressive, effective models for studying endotoxin induced uveitis

Researchers at Henan Province Eye Hospital in China have made great strides in studying endotoxin-induced uveitis (EIU) by creating a novel EIU model in zebrafish.  Uveitis is an ocular inflammation and one of the main causes of visual impairment, accounting for 10-15% of global blindness.  Mice have typically been the research animal of choice however

2023

Researchers find early signs of Alzheimer’s disease (AD) in the mouse retina and develop a non-invasive artificial intelligence-based system that could be used to diagnose the disease before the appearance of clinical symptoms

Progress in diagnosing and treating Alzheimer’s disease (AD) has been accelerating over the last few years. Until now, AD has been difficult to diagnose. The disease can be present years before distinguishable symptoms manifest. Non-invasive diagnostic tests have been lacking, and diagnosis often relies on memory, cognitive, and behavioral tests. In 2011, Koronyo-Hamaoui M, Koronyo

2023

Researchers at the University of Copenhagen demonstrate for the first time that diet induced obesity (DIO) leads to raised intracranial pressure (ICP) and subsequent clinically relevant symptom development.

In the paper “The impact of obesity‑related raised intracranial pressure in rodents” published in Scientific Reports journal, Westgate and collaborators used the Phoenix MICRON® image-guided OCT system, along with the Phoenix MICRON® Insight software, in the measurement of the retinal anatomical changes caused by intracranial hypertension in obese rats. The Problem: Intracranial pressure (ICP) measures the

2021

Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally

Bend, OR, USA, November 29, 2021 — The newly formed company, Phoenix-Micron, Inc., announced today it has completed the spin-out of the Phoenix MICRON® imaging platform from Phoenix Technology Group. This move is designed to increase focus and innovation in products designed to serve the eye and eye-brain research community. The new company, Phoenix-Micron, Inc.

1 2 3 5